phenytoin sodium
Generic: phenytoin sodium
Labeler: taro pharmaceuticals u.s.a., inc.Drug Facts
Product Profile
Brand Name
phenytoin sodium
Generic Name
phenytoin sodium
Labeler
taro pharmaceuticals u.s.a., inc.
Dosage Form
CAPSULE, EXTENDED RELEASE
Routes
Active Ingredients
phenytoin sodium 100 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
51672-4111
Product ID
51672-4111_231ef946-40f4-2149-e063-6394a90a16bb
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA040684
Listing Expiration
2026-12-31
Marketing Start
2006-09-05
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
516724111
Hyphenated Format
51672-4111
Supplemental Identifiers
RxCUI
UPC
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
phenytoin sodium (source: ndc)
Generic Name
phenytoin sodium (source: ndc)
Application Number
ANDA040684 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 100 mg/1
Packaging
- 10 BLISTER PACK in 1 CARTON (51672-4111-0) / 10 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK
- 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (51672-4111-1)
- 1000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (51672-4111-3)
- 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (51672-4111-6)
Packages (4)
51672-4111-0
10 BLISTER PACK in 1 CARTON (51672-4111-0) / 10 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK
51672-4111-1
100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (51672-4111-1)
51672-4111-3
1000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (51672-4111-3)
51672-4111-6
30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (51672-4111-6)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "231ef946-40f4-2149-e063-6394a90a16bb", "openfda": {"upc": ["0351672411114"], "unii": ["4182431BJH"], "rxcui": ["855671"], "spl_set_id": ["601f7353-225d-4a5d-9810-3869c2c21874"], "manufacturer_name": ["Taro Pharmaceuticals U.S.A., Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 BLISTER PACK in 1 CARTON (51672-4111-0) / 10 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK", "package_ndc": "51672-4111-0", "marketing_start_date": "20060905"}, {"sample": false, "description": "100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (51672-4111-1)", "package_ndc": "51672-4111-1", "marketing_start_date": "20060905"}, {"sample": false, "description": "1000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (51672-4111-3)", "package_ndc": "51672-4111-3", "marketing_start_date": "20060905"}, {"sample": false, "description": "30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (51672-4111-6)", "package_ndc": "51672-4111-6", "marketing_start_date": "20060905"}], "brand_name": "Phenytoin Sodium", "product_id": "51672-4111_231ef946-40f4-2149-e063-6394a90a16bb", "dosage_form": "CAPSULE, EXTENDED RELEASE", "pharm_class": ["Anti-epileptic Agent [EPC]", "Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]", "Cytochrome P450 2C8 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 2D6 Inducers [MoA]", "Cytochrome P450 3A Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "51672-4111", "generic_name": "Phenytoin Sodium", "labeler_name": "Taro Pharmaceuticals U.S.A., Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Phenytoin Sodium", "active_ingredients": [{"name": "PHENYTOIN SODIUM", "strength": "100 mg/1"}], "application_number": "ANDA040684", "marketing_category": "ANDA", "marketing_start_date": "20060905", "listing_expiration_date": "20261231"}